(Circulation. 2000;101:2405.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Significant Frequencies of T Cells With Indirect Anti-Donor Specificity in Heart Graft Recipients With Chronic Rejection
From the Departments of Immunology (P.I.H., P.D.M., R.J.B., M.H.-F., L.F., G.L., L.W., R.B., R.I.L.) and Cardiothoracic Surgery (P.I.H., K.T.), Imperial College School of Medicine, Hammersmith Hospital, London, and Department of Cardiothoracic Surgery (M.L.R., M.H.Y.), Harefield Hospital, Middlesex, UK.
Correspondence to Philip Hornick, Department of Cardiothoracic Surgery, Imperial College School of Medicine, Du Cane Road, Hammersmith Hospital, London W12 ONN, UK. E-mail philhrnck{at}aol.com
Background—The purpose of this study was to determine whether T cells with indirect allospecificity could be detected in heart transplant recipients with chronic rejection.
Methods and Results—Human T-cell clones were used to determine the most effective way to deliver major histocompatibility complex alloantigens for indirect presentation. Seven allograft recipients with evidence of progressive, chronic rejection were selected. Four heart graft recipients with no evidence of chronic rejection were used as controls. Peripheral blood T cells and antigen-presenting cells from the recipients were cultured with frozen/thawed stored donor cells or major histocompatibility complex class I–derived synthetic peptides in limiting dilution cultures and then compared with controls using tetanus toxoid and frozen/thawed third-party cells with no human leukocyte antigens in common with the donor. In 5 of 7 patients analyzed who had chronic rejection, elevated frequencies of T cells with indirect, anti-donor specificity (iHTLf) were detected. No such elevated iHTLf were detected in recipients without chronic rejection.
Discussion—iHTLf can be obtained from human transplant recipients, which supports the contention that the indirect pathway is involved in chronic transplant rejection.
Key Words: transplantation • immunology • rejection • immune system • lymphocytes
This article has been cited by other articles:
 |
|
 |
|
  B. P. Griffith, M. Haddad, and R. S. Poston Immunobiology of Heart and Heart-Lung Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1513 - 1538. [Full Text]
|
|
|
|
 |
|
 B. Mahesh, H.-S. Leong, A. McCormack, P. Sarathchandra, A. Holder, and M. L. Rose Autoantibodies to Vimentin Cause Accelerated Rejection of Cardiac Allografts Am. J. Pathol., April 1, 2007; 170(4): 1415 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. B. Herrera, D. Golshayan, R. Tibbott, F. S. Ochoa, M. J. James, F. M. Marelli-Berg, and R. I. Lechler A Novel Pathway of Alloantigen Presentation by Dendritic Cells J. Immunol., October 15, 2004; 173(8): 4828 - 4837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mirenda, I. Berton, J. Read, T. Cook, J. Smith, A. Dorling, and R. I. Lechler Modified Dendritic Cells Coexpressing Self and Allogeneic Major Histocompatability Complex Molecules: An Efficient Way to Induce Indirect Pathway Regulation J. Am. Soc. Nephrol., April 1, 2004; 15(4): 987 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Salama, N. Najafian, M. R. Clarkson, W. E. Harmon, and M. H. Sayegh Regulatory CD25+ T Cells in Human Kidney Transplant Recipients J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1643 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Game, M. P. Hernandez-Fuentes, A. N. Chaudhry, and R. I. Lechler CD4+CD25+ Regulatory T Cells Do Not Significantly Contribute to Direct Pathway Hyporesponsiveness in Stable Renal Transplant Patients J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Griffith and R. S. Poston Immunobiology of Heart and Heart-Lung Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1403 - 1426. [Full Text]
|
|
|
|
|
|
G. W. Haller, B. Lima, S. M. Kunisaki, S. Germana, C. Leguern, C. A. Huang, and D. H. Sachs MHC Alloantigens Elicit Secondary, But Not Primary, Indirect In Vitro Proliferative Responses J. Immunol., October 1, 2002; 169(7): 3613 - 3621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Freese and N. Zavazava HLA-B7 beta -pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses Blood, May 1, 2002; 99(9): 3286 - 3292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Najafian, A. D. Salama, E. V. Fedoseyeva, G. Benichou, and M. H. Sayegh Enzyme-Linked Immunosorbent Spot Assay Analysis of Peripheral Blood Lymphocyte Reactivity to Donor HLA-DR Peptides: Potential Novel Assay for Prediction of Outcomes for Renal Transplant Recipients J. Am. Soc. Nephrol., January 1, 2002; 13(1): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Baker, M. P. Hernandez-Fuentes, P. A. Brookes, A. N. Chaudhry, H. T. Cook, and R. I. Lechler Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy J. Immunol., December 15, 2001; 167(12): 7199 - 7206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. WOMER, J. R. STONE, B. MURPHY, A. CHANDRAKER, and M. H. SAYEGH Indirect Allorecognition of Donor Class I and II Major Histocompatibility Complex Peptides Promotes the Development of Transplant Vasculopathy J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2500 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lovegrove, G. J. Pettigrew, E. M. Bolton, and J. A. Bradley Epitope Mapping of the Indirect T Cell Response to Allogeneic Class I MHC: Sequences Shared by Donor and Recipient MHC May Prime T Cells That Provide Help for Alloantibody Production J. Immunol., October 15, 2001; 167(8): 4338 - 4344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Lee, K. Yamada, S. L. Houser, K. L. Womer, M. E. Maloney, H. S. Rose, M. H. Sayegh, and J. C. Madsen Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy PNAS, March 13, 2001; 98(6): 3276 - 3281. [Abstract] [Full Text] [PDF]
|
|